Associated Papers
A novel stop-gain pathogenic variant in FLT4 and a nonsynonymous pathogenic variant in PTPN11 associated with congenital heart defects.
Tabib A et al.
European Journal of Medical Research, 2022
Pulling back the curtain: The hidden functions of receptor tyrosine kinases in development.
Clark JF et al.
Current Topics in Developmental Biology, 2022
Development and physiological functions of the lymphatic system: insights from human genetic studies of primary lymphedema.
Martin-Almedina S et al.
Physiological Reviews, 2021
The physiological and pathological functions of VEGFR3 in cardiac and lymphatic development and related diseases.
Monaghan RM et al.
Cardiovascular Research, 2021
VEGFR-3 Signaling Regulates Triglyceride Retention and Absorption in the Intestine.
Shew T et al.
Frontiers in Physiology, 2018
FLT4/VEGFR3 and Milroy disease: novel mutations, a review of published variants and database update.
Gordon K et al.
Human Mutation, 2013
VEGFR-3 ligand-binding and kinase activity are required for lymphangiogenesis but not for angiogenesis.
Zhang L et al.
Cell Research, 2010
Recessive primary congenital lymphoedema caused by a VEGFR3 mutation.
Ghalamkarpour A et al.
Journal of Medical Genetics, 2009
Hereditary lymphedema type I associated with VEGFR3 mutation: the first de novo case and atypical presentations.
Ghalamkarpour A et al.
Clinical Genetics, 2006
Select a paper to view details